Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran ...
๐ฐ Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema - Intellia Therapeutics (Intellia Therapeutics) ๐ Source: https://news.google.com/rss/articles/CBMivgFBVV95cUxNSTU5ZWo2QXVHNFcxdURzeG1jNG5IcjMybDRsU1lURWZSUW1DRTZsYnRpdWMwd0xGWThYSmhnNmdZY1pRdElJcDZpSVRjcTFsd2IxNm1uYnAwZzRKN1VPY1BaZVBHVm1DX05JT2ptdzB4WUJxMXE3OW1uZHVpMXpRaFZNRDBMeENBZ0RRdGJTdC1LcFNxTTJxRlRTRi1EV01aLVRiWGtKUFNtOEdlU2xoQ2k0aHM0SkxwcTBIU09R?oc=5












